Fadia Kamal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The following is a list of academic promotions for tenured and tenure-line faculty members at Penn State, effective July 1, 2023.

Common anti-depressant may be first-ever treatment for osteoarthritis Researchers found that Paroxetine not only slows down cartilage degeneration, but also promotes cartilage health in both mice and human cartilage in vitro. Image: Fadia Kamal, Penn State Common anti-depressant may be first-ever treatment for osteoarthritis Sara LaJeunesse February 10, 2021 HERSHEY, Pa. — A disease of the joints, osteoarthritis affects more than 30 million adults and is the fifth-leading cause of disability in the United States. In a new study, scientists have discovered the cellular pathway that leads to ...

Nick has been writing and editing at New Atlas for over six years, where he has covered everything from distant space probes to self-driving cars to oddball animal science. He previously spent time at The Conversation, Mashable and The Santiago Times, earning a Masters degree in communications from Melbourne’s RMIT University along the way. 9 comments Please keep comments to less than 150 words. No abusive material or spam will be published. sidmehta February 12, 2021 04:21 AM If depression can affect the kidney, the heart, and now knee joint...

New research suggests that the antidepressant paroxetine could represent the first-ever disease-modifying treatment for osteoarthritis, and also indicates that other compounds that counteract abnormal activity in cartilage-maintaining cells could be repurposed into therapies for the disease.